People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

New and innovative mechanisms of action are constantly being discovered and developed into medicines that tackle a broad ...

Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

All NICE products on oesophageal cancer. Includes any guidance and quality standards.

Transitions into and out of inpatient mental health settings are an important time for young people and their families. Providing expert support and taking enough time to plan, particularly at ...

To get a licence, the manufacturer of the medicine has to provide evidence that shows that the medicine works well enough and is safe enough to be used for a specific condition and for a specific ...

For further information on the guideline development process, please see how we develop NICE guidelines ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

All NICE products on physical activity. Includes any guidance and quality standards.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.